Packham, J, Arkell, P, Sheeran, T, Brownfield, A, Cadwgan, A and Ryan, S (2017) Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication: a quantitative study. Clinical Rheumatology, 36 (11). pp. 2595-2600. ISSN 0770-3198

[thumbnail of J Packham - Patient experiences, attitudes and expectations towards receiving information about anti TNF medication.pdf]
J Packham - Patient experiences, attitudes and expectations towards receiving information about anti TNF medication.pdf - Published Version
Available under License Creative Commons Attribution.

Download (269kB) | Preview


The objective of the study was to measure patient attitudes and experience of information received during drug counselling for rheumatoid arthritis (RA) medications. This is a cross-sectional UK postal questionnaire study. Three RA patient groups—disease-modifying antirheumatic drugs (DMARDs) only, first anti-tumour necrosis factor (anti-TNF) and failed anti-TNF—were sent postal questionnaires. Data on patient history/demographics, drug counselling experience, knowledge of drug side effects, attitudes to vaccinations, cancer screening and blood borne virus testing was collected; 264/679 (39%) patients responded (median age 65 years, 66% female, median disease duration 15 years). Drug information from rheumatology nurses, rheumatology doctors and information leaflets was most useful. Thirty-eight percent of respondents felt reassured by information received, but 37% felt more worried. Forty percent of participants were aware of important drug side effects. Although 42–65% of patients understood they should temporarily halt anti-TNF therapy with concurrent infection, 75% of patients recalled continuing therapy despite infection. Thirteen percent believed that all vaccinations (including travel vaccinations) were safe while taking anti-TNF. Uptake of UK cancer screening programmes was between 87 and 94%, except prostate screening (47%). Most participants were not aware that they may need to discontinue their anti-TNF if they developed cancer. The majority of participants felt neutral/reassured by the prospect of viral hepatitis (95%) and HIV (91%) testing. Although drug counselling is a well-established part of clinical care, there is potential for further improvement to ensure that patients’ knowledge empowers them to act safely. Particular areas for improvement included the following: patients halting DMARDs/anti-TNF therapy during infections, knowledge regarding vaccinations and prostate cancer screening uptake.

Item Type: Article
Uncontrolled Keywords: Patient education; Rheumatoid arthritis
R Medicine > RA Public aspects of medicine
R Medicine > RC Internal medicine > RC925 Diseases of the musculoskeletal system
Divisions: Faculty of Medicine and Health Sciences > Primary Care Health Sciences
Depositing User: Symplectic
Date Deposited: 23 May 2017 14:06
Last Modified: 20 Mar 2019 10:26

Actions (login required)

View Item
View Item